1. HBW Insight
  2. >>Archive

FDA Holds Line On Omega-3 Claims, But Gives Enforcement Discretion For More

 
• By Malcolm Spicer

Agency says "some credible evidence" suggests intake of  EPA and DHA "may reduce the risk of hypertension by lowering blood pressure, this evidence is inconclusive and highly inconsistent" and does not support actual approval of a qualified health claim.

Red heart and a stethoscope on backgrouund - Image

The US Food and Drug Administration will exercise enforcement discretion for five additional qualified health claims for blood pressure and coronary heart disease risk reduction to be used with omega-3 supplements.

The agency announced the decision on 19 June in its response to a citizen petition by the Global Organization for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

FTC Consumer Privacy Policy Driven By ‘Straw Man’ Arguments – Commissioner Holyoak

 
• By Eileen Francis

The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.

FTC’s New Commissioner ‘Dismayed’ By Agency Overreach

 
• By Eileen Francis

FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements. 

Beauty Brands Not On TikTok Shop ‘Really Missing Out’ – KO-Pack

 
• By Eileen Francis

At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

More from HBW Insight

Navamedic Adds OTC Naloxone With DNE Pharma Acquisition

 
• By Tom Gallen

Norway's Navamedic will move into the addiction treatment market with the acquisition of DNE Pharma, adding to its portfolio an OTC opioid overdose reversal spray.

Kenvue’s Latest Tylenol Brand Launch Steers Consumers To Dietary Supplement Section

 
• By Malcolm Spicer

The firm doesn’t hold back on linking Muscle & Joint turmeric and tamarind formulation and Muscle & Joint + Stress also containing sceletium extract to the Tylenol brand while also pointing out that neither formulation contains acetaminophen

CIR Panel Tentatively Finds Hair Dye 4-Chloro-2-Aminophenol Unsafe, Despite Lack Of Use

 
• By Lauren Nardella

Six panelists of the Expert Panel for Cosmetic Ingredient Safety voted in favor of issuing a tentative unsafe designation for hair dye 4-chloro-2-aminophenol, though the substance has no reported uses on the US market.